|
⚲
|
| Keyboard |
| George Scangos | |
|---|---|
| Firm | |
| Address | c/o Rezo Therapeutics, Inc 455 Mission Bay Boulevard South, Ste 525 San Francisco, CA 94158 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Octave Bioscience Inc | 021-541925 | Director | 31.8 M of 53.7 M |
||
| Voyager Therapeutics Inc | 021-502725 | Director | 20.0 M of 20.0 M |
||
| Octave Bioscience Inc | 021-498050 | Director | 7.0 M of 7.0 M |
||
| Octave Bioscience Inc | 021-498049 | Director | 32.5 M of 37.5 M |
||
| Encentrio Therapeutics Inc | 021-477694 | Director | 0.4 M of 0.4 M |
||
| REZO Therapeutics Inc | 021-466228 | Director | 68.1 M of 80.1 M |
||
| Octave Bioscience Inc | 021-385495 | Director | 32.0 M of 32.0 M |
||
| VIR Biotechnology Inc | 021-366581 | Executive Officer | 32.4 M of 32.4 M |
||
| VIR Biotechnology Inc | 021-366580 | Executive Officer | 250.0 M of 250.0 M |
||
| VIR Biotechnology Inc | 021-315844 | Executive Officer | 66.0 M | ||
| Decibel Therapeutics Inc | 021-250116 | Director | 32.3 M of 57.8 M |
||
| Exelixis Inc | 021-93976-7L | Executive Officer | of 3.0 M |
||